SCHEMBL23001046

SCHEMBL23001046

CCCCCCCCCCCC[S+]([O-])c1ccccc1[S+](C)[O-]

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.34
CES1 P23141 2/20 0.34
LIPG Q9Y5X9 1/20 0.33
ALDH1A1 P00352 2/20 0.32
DNM1 Q05193 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
KCNH2 Q12809 3/20 0.32
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EPHX2 P34913 1/20 0.31
TSHR P16473 1/20 0.31
PKM P14618 1/20 0.31
LMNA P02545 1/20 0.31
FAAH O00519 1/20 0.30
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23016861 0.82 P2RX7 (0.36) CES2CES1LIPGALDH1A1DNM1
SCHEMBL17817514 0.81 ALDH1A1 (0.40) CES2CES1ALDH1A1MEN1TP53
SCHEMBL233478 0.76 ALDH1A1 (0.45) CES2CES1ALDH1A1MEN1TP53
SCHEMBL17817574 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL7329821 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL5073895 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL10357516 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL9815169 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL587114 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1
SCHEMBL12040835 0.76 CES2 (0.41) CES2CES1LIPGALDH1A1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3229811-B1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS GRI BIO INC (US) 2021-02-24 EP disclosed
EP-3229811-B1 PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS GRI BIO INC (US) 2021-02-24 EP disclosed